3 Canadian Health Entities to Jointly Develop Therapies for Parkinson’s, Other Neurological Diseases
The Vancouver-based Centre for Drug Research and Development (CDRD), the Montreal Neurological Institute and Hospital at McGill University (MNI) and Merck Canada have jointly established an innovative platform to develop and advance new drugs for Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and other neurological illnesses. The initiative, dubbed NeuroCDRD, initially…